ARVINAS, INC. Fair Value Adjustment of Warrants
ARVINAS, INC. (ARVN) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2021-03-01
- ARVINAS, INC. fair value adjustment of warrants for the quarter ending 2019-12-31 was $0.00.
- ARVINAS, INC. fair value adjustment of warrants for the quarter ending 2019-09-30 was $0.00.
- ARVINAS, INC. fair value adjustment of warrants for the quarter ending 2019-06-30 was $0.00.
- ARVINAS, INC. fair value adjustment of warrants for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- ARVINAS, INC. fair value adjustment of warrants for fiscal 2020 was $0.00.
- ARVINAS, INC. fair value adjustment of warrants for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- ARVINAS, INC. fair value adjustment of warrants for fiscal 2018 was $193.78K.
- ARVINAS, INC. fair value adjustment of warrants for fiscal 2017 was -$5.87K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-01 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $0.00 10-K · filed 2021-03-01 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-04 | $0.00 derived: sum of 2 quarters · filed 2019-11-04 | $0.00 10-Q · filed 2019-11-04 | $0.00 derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-05 | $0.00 10-Q · filed 2019-08-05 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $0.00 derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | -$2.52K derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | -$2.52K derived: sum of 3 quarters · filed 2021-03-01 | $193.78K 10-K · filed 2021-03-01 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-04 | -$2.52K derived: sum of 2 quarters · filed 2020-03-16 | $193.78K 10-Q · filed 2019-11-04 | $192.25K derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-06-30 | -$2.52K 10-K · filed 2020-03-16 | $193.78K 10-Q · filed 2019-08-05 | $192.25K derived: sum of 3 quarters · filed 2020-03-16 | $190.70K derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-03-31 | $196.29K 10-K · filed 2020-03-16 | $194.76K derived: sum of 2 quarters · filed 2020-03-16 | $193.22K derived: sum of 3 quarters · filed 2020-03-16 | $191.76K derived: sum of 4 quarters · filed 2020-03-16 |
| 2017-12-31 | -$1.53K 10-K · filed 2019-03-26 | -$3.08K derived: sum of 2 quarters · filed 2019-03-26 | -$4.54K derived: sum of 3 quarters · filed 2019-03-26 | -$5.87K 10-K · filed 2019-03-26 |
| 2017-09-30 | -$1.55K 10-K · filed 2019-03-26 | -$3.00K derived: sum of 2 quarters · filed 2019-03-26 | -$4.34K 10-Q · filed 2018-11-14 | |
| 2017-06-30 | -$1.46K 10-K · filed 2019-03-26 | -$2.79K derived: sum of 2 quarters · filed 2019-03-26 | ||
| 2017-03-31 | -$1.33K 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |